Dr Reddy’s Labs Q3 Results: Cons PAT rises 2% YoY to Rs 1,413 crore, revenue up 16% – The Economic Times

1. Dr Reddy’s Labs Q3 Results: Cons PAT rises 2% YoY to Rs 1,413 crore, revenue up 16%  The Economic Times
2. Dr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%  Mint
3. Dr Reddy’s Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth  Moneycontrol
4. Dr Reddy’s Q3 results: Check earnings preview and options strategy ahead of results  Upstox
5. Dr. Reddy Lab Q3 Results: Net profit likely to remain flat around ₹1360-65 cr  BusinessLine

 Dr Reddy’s Labs Q3 Results: Cons PAT rises 2% YoY to Rs 1,413 crore, revenue up 16%  The Economic TimesDr Reddy’s Labs Q3 Results: Profit grows 2% YoY to ₹1413 crore; revenue up 16%  MintDr Reddy’s Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth  MoneycontrolDr Reddy’s Q3 results: Check earnings preview and options strategy ahead of results  UpstoxDr. Reddy Lab Q3 Results: Net profit likely to remain flat around ₹1360-65 cr  BusinessLine  Top stories – Google News